Envestnet Asset Management
CLBT icon

Envestnet Asset Management’s Cellebrite CLBT Stock Holding History

Envestnet Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
28,604
+11,487
+67% +$152K ﹤0.01% 4215
2026
Q1 		$236K Sell
17,117
-21,847
-56% -$329K ﹤0.01% 4422
2025
Q4 		$703K Sell
38,964
-7,867
-17% -$141K ﹤0.01% 3475
2025
Q3 		$868K Buy
46,831
+28,589
+157% +$449K ﹤0.01% 3412
2025
Q2 		$292K Sell
18,242
-8,130
-31% -$145K ﹤0.01% 4035
2025
Q1 		$512K Buy
+26,372
New +$555K ﹤0.01% 3608

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Envestnet Asset Management's CLBT Position: Q2 2026 in Review

Envestnet Asset Management increased its Cellebrite (CLBT) stake by 67% in Q2 2026, buying an estimated $152K and bringing the position to 28,604 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #4215.

Envestnet Asset Management first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $868K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Envestnet Asset Management held 28,604 shares of Cellebrite worth $418K as of Q2 2026.
  • Envestnet Asset Management bought 11,487 Cellebrite shares in Q2 2026, an estimated $152K.
  • Cellebrite made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4215 holding.
  • Envestnet Asset Management first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
  • Envestnet Asset Management's Cellebrite position peaked at $868K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.